Humoral and cellular response of COVID‐19 vaccine among solid organ transplant recipients: A systematic review and meta‐analysis

HS Meshram, V Kute, H Rane, R Dave… - Transplant Infectious …, 2022 - Wiley Online Library
Background We aimed to analyze the humoral and cellular response to standard and
booster (additional doses) COVID‐19 vaccination in solid organ transplantation (SOT) and …

Immunogenicity and risk factors associated with poor humoral immune response of SARS-CoV-2 vaccines in recipients of solid organ transplant: a systematic review …

K Manothummetha, N Chuleerarux… - JAMA network …, 2022 - jamanetwork.com
Importance Recipients of solid organ transplant (SOT) experience decreased
immunogenicity after COVID-19 vaccination. Objective To summarize current evidence on …

Humoral immune response following SARS-CoV-2 vaccination in liver transplant recipients

L Timmermann, B Globke, G Lurje, M Schmelzle… - Vaccines, 2021 - mdpi.com
As COVID-19 remains an issue in transplantation medicine, a successful vaccination can
prevent infections and life-threatening courses. The probability of poor immune response in …

[HTML][HTML] Seroconversion rates in kidney transplant recipients following SARS-CoV-2 vaccination and its association with immunosuppressive agents: a systematic …

MR Iryaningrum, A Cahyadi, FA Damara… - Clinical and …, 2023 - ncbi.nlm.nih.gov
This systematic and meta-analysis aims to evaluate humoral and cellular responses to the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine among kidney …

Breakthrough infections following mRNA SARS-CoV-2 vaccination in kidney transplant recipients

A Mazuecos, F Villanego, S Zarraga, V López… - …, 2022 - journals.lww.com
Background. The clinical effectiveness of coronavirus disease 2019 (COVID-19) vaccination
in kidney transplant (KT) recipients is lower than in the general population. Methods. From …

Association between SARS-CoV-2 messenger RNA vaccines and lower infection rates in kidney transplant recipients: a registry-based report

I Zahradka, V Petr, I Modos, M Magicova… - Annals of Internal …, 2022 - acpjournals.org
Background: The real-world protection provided by SARS-CoV-2 messenger RNA (mRNA)
vaccines to kidney transplant recipients (KTRs) remains uncertain. Objective: To study the …

Low switched memory B cells are associated with no humoral response after SARS-CoV-2 vaccine boosters in kidney transplant recipients

M Seija, J García-Luna, F Rammauro… - Frontiers in …, 2023 - frontiersin.org
Introduction The humoral response after SARS-CoV-2 vaccination and boosters in kidney
transplant recipients (KTRs) is heterogeneous and depends on immunosuppression status …

COVID-19 breakthrough infections in vaccinated kidney transplant recipients

X Zhang, R Weng, F Liu, Y Xie, Y Jin, Q Li, G Huang… - Vaccines, 2022 - mdpi.com
Coronavirus disease 2019 (COVID-19) is associated with increased morbidity and mortality
among kidney transplant recipients (KTRs). The administration of the severe acute …

[HTML][HTML] Update of the recommendations on the management of the SARS-CoV-2 coronavirus pandemic (COVID-19) in kidney transplant patients

V López, A Mazuecos, F Villanego… - Nefrología (English …, 2023 - Elsevier
Abstract SARS-CoV-2 infection (COVID-19) has had a significant impact on transplant
activity in our country. Mortality and the risk of complications associated with COVID-19 in …

[HTML][HTML] A systematic review assessing the effectiveness of COVID-19 mRNA vaccines in chronic kidney disease (CKD) individuals

SA Malik, K Modarage, P Goggolidou - F1000Research, 2022 - ncbi.nlm.nih.gov
Background: SARS-CoV-2 is a coronavirus that has rapidly spread across the world with a
detrimental effect on the global population. Several reports have highlighted an increased …